Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc19d8d6ba9ad5c1fa5770341472b56 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
filingDate |
2002-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2003-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48088875a26cbe64bb284c156d49b480 |
publicationDate |
2003-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6589745-B2 |
titleOfInvention |
CIF130 inhibits cell cycle progression |
abstract |
A human gene termed CIF130 and its expression products can alter the spatial or temporal patterns of mitosis or cell cycle progression of a human cell. Methods of treating disorders involving alterations in the regulation of mitosis or cell cycle progression utilize the gene and its expression product. Genes whose expression is dependent upon CIF130 expression can be identified. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9689874-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10867706-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9724430-B2 |
priorityDate |
1998-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |